AVITA Medical is a publicly listed, global regenerative medicine company that provides a novel approach to skin regeneration. Our products provide innovative treatment solutions derived from the regenerative properties of a patient’s own skin. AVITA’s proprietary technology has evidence for additional skin applications beyond treating burns, such as chronic and traumatic wounds, scar revision, and vitiligo.
CONTACT US TODAY
MANAGEMENT TEAM BOARD OF DIRECTORSRECELL® is FDA approved in the USA for the treatment of acute thermal burn wounds in patients 18 years of age and over, TGA-registered in Australia, CE-marked in Europe.
RECELL® is FDA approved in the USA for the treatment of acute thermal burn wounds in patients 18 years of age and over, TGA-registered in Australia, CE-marked in Europe.
At AVITA Medical we care deeply about patients and always put them first. We aim to transform lives and improve outcomes with more effective therapies than the current standard of care.
Being a leader in regenerative medicine means innovating with purpose. At AVITA Medical we develop novel therapeutics to treat life-altering conditions through the development of transformative therapies.
At AVITA Medical, everyone has an impact and success is achieved through respect, integrity, and accountability. We are united through our passion and dedication to improving the lives of patients through regenerative medicine.
We aim to increase corporate value and exceed shareholder expectations through the development and delivery of therapies in regenerative medicine that address unmet medical needs.
We deliver shareholder value through managed leadership that
has an established and impressive track record in developing,
marketing, and commercializing therapeutic products for use
throughout the world.
Or Call US Customer Support
1-833-GO-AVITA